3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Metabolic Syndrome
1
Lymphoma, Non-Hodgkin
1
Heart Failure
1
Cardiovascular Diseases
1
Cardiotoxicity
1
Cardiomyopathies
1
Interventions
semaglutide
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Vascular Stiffness
1
Ultrasonography
1
Topiramate
1
Tirzepatide
1
Testosterone
1
Qsymia
1
Pulse Wave Analysis
1
Pioglitazone
1
Phentermine
1
Observation
1
Naltrexone
1
Medical History Taking
1
Liraglutide
1
Human Growth Hormone
1
Hematologic Tests
1
Growth Hormone
1
Gonadotropin-Releasing Hormone
1
Glucagon-Like Peptide-1 Receptor
1
Gastric Bypass
1
Electrocardiography
1
Echocardiography
1
Diethylpropion
1
Dietary Approaches To Stop Hypertension
1
DNA
1
Colonoscopy
1
Bupropion
1
Blood Specimen Collection
1
Blood Pressure
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Metabolic Syndrome
×
Vascular Stiffness
×
Clear all
NCT07041827
2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
217 enrolled